Stocks to Keep Eyes On: Dicerna Pharmaceuticals (NASDAQ:DRNA), Kinross Gold Corporation (NYSE:KGC), Alcatel Lucent SA (ADR) (NYSE:ALU), Clorox (NYSE:CLX), Endologix (NASDAQ:ELGX)


On January 13, Dicerna Pharmaceuticals, Inc (NASDAQ:DRNA), announced the presentation of new preclinical data on its Dicer substrate short interfering RNA (DsiRNA) therapeutics targeting MYC and β-catenin (CTNNB1) oncogenes in models of hepatocellular carcinoma (HCC) and colorectal cancer (CRC). On Tuesday shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) closed at $21.71.

On January 23, Kinross Gold Corporation (NYSE:KGC) announced that it has extended its offer to exchange up to $500 million principal amount of its 5.95% senior notes, due 2024, to Jan 23, 2015. The Notes (the “New Notes”), which are registered under the Securities Act of 1933, will be exchanged for all of the company’s outstanding unregistered 5.95% senior notes due 2024 (the “Old Notes”). Kinross Gold Corporation (NYSE:KGC) in last trading activity advanced 2.06% to close at $3.46. Company weekly performance is -4.42% while its quarterly performance stands at 27.68%. Kinross Gold Corporation (NYSE:KGC) is -36.40% away from its 52 week high.

Market-leading South African operator Vodacom has commissioned Alcatel-Lucent SA (ADR) (NYSE:ALU) to build a gigabit passive optical networking (GPON) solution to expand into the enterprise and residential markets. On Tuesday shares of Alcatel Lucent SA (ADR) (NYSE:ALU) closed at $3.47. Company’s sales growth for last 5 years was -3.20% and EPS growth for next 5 years is recorded as 0.00%.

The Clorox Company (NYSE:CLX)’s cash dividend payment of $0.74 per share is scheduled to be paid on February 13, 2015. Shareholders who purchased CLX stock prior to the ex-dividend date are eligible for the cash dividend payment. The Clorox Company (NYSE:CLX) has 0.20% insider ownership while its institutional ownership stands at 76.10%. In last trading activity company’s stock closed at $108.00.

BTIG Research cut shares of Endologix Inc (NASDAQ:ELGX) from a buy rating to a neutral rating in a research note issued to investors on Thursday, TheFlyOnTheWall.com reports. On last trading day Endologix Inc. (NASDAQ:ELGX) fell -0.48% to close at $14.50. Its volatility for the week is 2.46% while volatility for the month is 3.42%. ELGX’s sales growth for past 5 years was 28.50% and its EPS growth for past 5 years was 1.50%. Endologix Inc. (NASDAQ:ELGX) monthly performance is -5.54%.


Leave a Reply

Your email address will not be published. Required fields are marked *